Cochlear Limited (CHEOF)
OTCMKTS · Delayed Price · Currency is USD
197.00
-3.37 (-1.68%)
Sep 9, 2025, 1:53 PM EDT
Cochlear Revenue
In the fiscal year ending June 30, 2025, Cochlear had annual revenue of 2.34B AUD with 4.81% growth. Cochlear had revenue of 1.17B in the half year ending June 30, 2025, with 11.46% growth.
Revenue
2.34B AUD
Revenue Growth
+4.81%
P/S Ratio
8.38
Revenue / Employee
426.02K AUD
Employees
5,500
Market Cap
12.88B USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 2.34B | 107.50M | 4.81% |
Jun 30, 2024 | 2.24B | 299.50M | 15.47% |
Jun 30, 2023 | 1.94B | 287.80M | 17.46% |
Jun 30, 2022 | 1.65B | 150.70M | 10.06% |
Jun 30, 2021 | 1.50B | 177.00M | 13.40% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
HealthLynked | 2.58M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Cochlear News
- 25 days ago - Cochlear reports FY results - Seeking Alpha
- 26 days ago - Cochlear Ltd (CHEOF) (FY25) Earnings Call Highlights: Navigating Growth and Challenges - GuruFocus
- 26 days ago - Cochlear CEO depends on built-up inventory as some export licenses lag - CNBC
- 26 days ago - Full Year 2025 Cochlear Ltd Earnings Call Transcript - GuruFocus
- 26 days ago - Cochlear Limited 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 26 days ago - Cochlear Limited (CHEOF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Cochlear tips higher earnings this year, slower first-half - The Australian Financial Review
- 26 days ago - ASX 200 LIVE: ASX to open modestly higher, results pending from Cochlear, Mirvac, US equities end little changed - The Australian Financial Review